MEDISCA AUSTRALIA: Non-Sterile Training - 24-26 July, 2020
The Practice-based Activity will provide compounding pharmacists and technicians with the competency to prepare current and viable pharmacotherapeutic non-sterile dosage forms. Unique concepts will be taught facilitating a decision-making process the pharmacist and technician can apply in their day-to-day practice.
Consideration will be given to meeting the physician’s prescription and patient-specific need, compliance-related solutions, medical necessity, and legal and regulatory guidelines. A significant emphasis will be placed on quality assurance and quality control as it relates to dosage form design, pharmaceutical calculations and the validation of preparatory procedures that are part of Master Formulation Records.
Practical techniques and technology-related applications are developed through hands-on experience in a compounding laboratory environment where pharmacists and technicians will be trained in all aspects of non-sterile preparatory procedures. Pharmacists and technicians have the opportunity to develop important aspects of a business development and marketing plan.
Pharmacists and Technicians new to compounding or with an existing compounding practice.
OVERALL LEARNING OBJECTIVES OF SELF-STUDY EVENT FOR PHARMACISTS
1. Relate unique and essential central core concepts
2. Describe regulatory framework requirements
3. Discuss standards of practice for non-hazardous and hazardous drug compounding
4. Explain components of a standard operating procedure
5. Apply business, marketing, and sales for a successful practice
6. Explain characteristics for routes of delivery in non-sterile compounding
7. Describe the chemical composition of different dosage forms
8. Identify laboratory practices, procedures and preparatory techniques related to the compounding of non-sterile dosage forms
9. Relate excipients to dosage forms, chemical composition, and routes of delivery
10. Relate base types to dosage forms, chemical composition, and routes of delivery
11. Illustrate the importance of drug monographs and certificates of analysis to compounding
12. Describe techniques and technology used during compounding
13. Apply the components of process development
14. Describe the components of a master formulation record
15. Discuss the requirements of a compounding record
*For Technicians, please refer to the workbook for Learning Objectives.
OVERALL LEARNING OBJECTIVES OF LIVE EVENT FOR PHARMACISTS
1. Explain compounding as a viable therapeutic option
2. Express unique marketing messages in support of a compounding practice
3. Demonstrate the ability to manage expenses and revenues using a financial spreadsheet
4. Assess acquisition costs in order to establish selling prices related to a compounding practice
5. Write a standard operating procedure
6. Apply regulations and standards to a non-hazardous and hazardous drug compounding practice
7. Develop preparatory procedures for solutions and dispersions; suspensions and emulsions
8. Solve pharmaceutical calculations used in pharmacy compounding
9. Relate process development to the establishment of a master formulation record
10. Prepare a master formulation record
11. Design a non-sterile compounding facility in compliance with standards of practice
12. Prepare a series of non-sterile compounded preparations
13. Apply qualitative and quantitative assessments to compounded preparations
*For Technicians, please refer to the workbook for Learning Objectives.
This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.
Activity material is Copyright© 2003-2020 LP3 Network Inc.
Registration and Sign-in:
7:30am - 8:00am
8:00am - 5:00pm
Activity participants are required to achieve a 75% passing grade associated with a self-study learning assessment prior to attending the live event. Full attendance and the completion of an activity evaluation and practical skill set competency evaluation are a compulsory requirement to achieve credit for the live event.
The training will take place at the MEDISCA Australia Facility.
BRANKO RADOJKOVIC, B Pharm
Pharmacist, Royal Prince Alfred Hospital; Training Facilitator, MEDISCA Australia
CLAIRE TARGETT, B. Pharm
Pharmacist Capital Chemist Charnwood; Training Facilitator, MEDISCA Australia.
KEN SPEIDEL, RPh, BS Pharm, PharmD, FIACP, FACA
Vice President, Gates Healthcare Associates; Surveyor, ACHC/PCAB; Fellow, IACP and ACA
MARK FILOSI, BS Pharm, RPh
Compounding Pharmacist and Co-Founder, Family Care Pharmacy; Surveyor, ACHC/PCAB.
PATRICIA ULLMANN, B. Pharm
Training and Technical Services Manager, MEDISCA Australia.
PAUL CAMERON, BPharm
Pharmacist, Dallas Parade Compounding Pharmacy; Training Facilitator, MEDISCA Australia.
REBECCA O’GRADY, BPharm, MPS GradCertPharmPrac
Technical Support Services Pharmacist, MEDISCA Australia
TAMMY NGUYEN, BPharm, MPS
Compounding Pharmacist, MEDISCA Australia.
VALENTINA KARAN, BPharm
Product Development Management, The Compounding Pharmacy Australia; Consultant, MEDISCA Australia.
Note: Facilitators are subject to change.
This CPD event has been accredited for 48 hours of Group-2 CPD (or 96 CPD credits), suitable for inclusion in an individual pharmacists CPD plan. The activity accreditation expires 1 May 2022.
CANCELLATION AND REFUND POLICY
In the event that MEDISCA Australia cancels a course, MEDISCA Australia’s sole liability shall be course repayment. In no event shall MEDISCA Australia be responsible for any costs arising from such cancellation, including but not limited to travel and/or accommodation.In the event a Registrant cancels their enrollment in a CPD Activity, a written request must be sent to MEDISCA Australia requesting ‘Cancellation without Transfer’ to an alternate live CPD Activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. MEDISCA Australia shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to MEDISCA Australia in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, MEDISCA Australia will not issue any refunds, only transfer to an alternate live activity event date.This cancellation and refund policy is specific to courses offered in Australia. To obtain information on the cancellation and refund policy for courses offered outside of Australia, please speak to a MEDISCA Australia representative or refer to your course-specific registration page.
TRANSFER POLICY – AUSTRALIA COURSES ONLY
This transfer policy is only applicable to courses that are offered in Australia. Transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity event date. Failure to submit “Transfer Request” at least 14 days prior to original live activity event date will default to “Cancellation and Refund Policy”. Transfer policy can only apply one (1) time. Transfer to a new live event date must be within current calendar year. Failure to attend the new live activity event will lead to no refund and will no longer be transferable. Confirmation of new activity date is subject to the approval by MEDISCA Australia based on the number of available seats within the selected live activity event.